Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cardinal Health, Inc. (NYSE: CAH) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cardinal Health is an Ohio corporation whose common shares trade on the New York Stock Exchange under the symbol CAH, as noted in multiple Form 8-K filings. These documents give investors detailed insight into the company’s financial condition, governance, capital structure, and material events.
Cardinal Health regularly files Form 8-K current reports to announce significant developments. Recent 8-K filings include disclosures about quarterly and annual financial results, updates to fiscal 2026 non-GAAP earnings per share outlook, entry into material definitive agreements such as credit facilities and receivables purchase amendments, public offerings of notes to help fund acquisitions like Solaris Health, and the completion of those offerings. Other 8-Ks document matters such as the 2025 Annual Meeting of Shareholders and voting results on director elections, say-on-pay, and auditor ratification.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) offers extensive information on corporate governance, Board composition, executive compensation, and shareholder voting items. Cardinal Health’s proxy materials describe its strategic priorities, fiscal performance highlights, Board skills and refreshment, and engagement with shareholders.
Through Stock Titan, users can review Cardinal Health’s periodic and current reports and use AI-powered tools to summarize key points from lengthy filings. These tools help explain complex sections, highlight items such as non-GAAP metrics definitions, capital markets transactions, and credit agreements, and make it easier to track themes like Specialty growth, distribution network investments, and capital allocation. The filings page also surfaces relevant exhibits, including indentures, underwriting agreements, and amendments to financing arrangements, giving a structured view of Cardinal Health’s obligations and governance framework.
Cardinal Health (CAH) director reported an equity award. On 11/05/2025, the reporting person acquired 1,067 restricted share units at no cost. The award will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier. Following this grant, the director beneficially owned 7,536 common shares directly.
Cardinal Health (CAH) director reported a routine equity grant on 11/05/2025. The filing shows an acquisition of 1,067 common shares at $0, reflecting a grant of restricted share units. Following the transaction, the director’s beneficial ownership stands at 27,624 shares, held directly.
The restricted share units will vest on November 5, 2026, or if the 2026 Annual Meeting of Shareholders occurs earlier, on the meeting date.
Cardinal Health (CAH) reported an insider equity award. A company director acquired 1,702 common shares on 11/05/2025 via an award priced at $0, reflecting a grant of restricted share units. Following the transaction, the director beneficially owns 64,194 shares directly.
The restricted share units are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Cardinal Health (CAH) reported an insider equity grant. A director acquired 1,067 restricted share units on November 5, 2025, recorded at $0 per unit. Following the transaction, the reporting person beneficially owns 22,868 common shares, held directly. The RSUs will vest on November 5, 2026, or, if the 2026 Annual Meeting of Shareholders occurs before that date, they will vest on the meeting date.
Cardinal Health (CAH) director filed a Form 4 reporting a grant of 1,067 restricted share units on November 5, 2025 at $0. Following the award, the reporting person beneficially owns 32,264 shares, held directly.
The RSUs will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
Cardinal Health (CAH) reported voting results from its 2025 Annual Meeting. Shareholders elected 12 director nominees to serve until the 2026 Annual Meeting. The advisory vote on executive compensation passed with 168,382,554 votes For, 17,271,117 Against, and 1,513,298 Abstained.
Shareholders also ratified Ernst & Young LLP as the independent auditor for the fiscal year ending June 30, 2026, with 195,705,020 For, 12,253,800 Against, and 310,216 Abstained. Director elections included standard broker non-votes of 21,102,067 across proposals where applicable.
Cardinal Health (CAH) reported a director’s equity grant. On 11/05/2025, the director acquired 1,067 common shares via a grant of restricted share units at a stated price of $0.
Following the transaction, the director beneficially owns 15,373 shares, held directly. The restricted share units will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Cardinal Health (CAH) director reported an equity award on a Form 4. On 11/05/2025, the director acquired 1,067 restricted share units at a price of $0. Following the transaction, the director beneficially owned 14,848 shares, held directly.
The RSUs will vest on November 5, 2026, except that if the 2026 Annual Meeting of Shareholders occurs before that date, they vest on the meeting date.
Cardinal Health (CAH) disclosed on a Form 4 that a director received 1,067 restricted share units on 11/05/2025 at a stated price of $0. The award will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
Following this grant, the reporting person beneficially owns 8,086 common shares, held directly. This reflects routine director equity compensation and does not indicate a sale of shares.
Cardinal Health (CAH) reported a director equity grant. On 11/05/2025, a board member acquired 1,067 restricted share units at $0, bringing directly held common shares to 4,085 after the transaction.
The grant will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
